Form 4 for LQDA Liquidia Corp

Accepted 2022-07-20 00:00:00 ET · period of report 2022-07-18 · accession 0001104659-22-081182 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-07-20	2022-07-18	LQDA	Saggar Rajeev	Chief Medical Off	A - Grant	$0.00	+93.8K	93.8K	New	$0
D	2022-07-20	2022-07-18	LQDA	Saggar Rajeev	Chief Medical Off	A - Grant	$0.00	+200.0K	200.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-07-18	A	A	93,834	$0.00	93,834	D	—	—	(F2) 50% of the RSUs shall vest on July 18, 2023 and the remaining RSUs shall vest ratably on a quarterly basis over two years thereafter, subject to the Reporting Person's employment with the Issuer on each such vesting date; provided, however, that the RSUs shall become fully vested in the event that the Reporting Person's employment is terminated due to his death or Disability or is terminated by the Company without Cause (as such terms are defined in the Reporting Person's Employment Agreement).
2	Derivative	Non-Qualified Stock Option (Right to Buy)	2022-07-18	A	A	200,000	$0.00	200,000	D	$3.73 · — to 2032-07-18	200,000 Common Stock	(F3) The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, subject to the Reporting Person's employment with the Issuer on each such vesting date.